An atypical adolescent case of leukocyte adhesion deficiency I caused by a novel ITGB2 splicing variant with successful immune reconstitution following hematopoietic stem cell transplantation
Clinical and Experimental Immunology · 21.01.2025 · 219 (1)
DOI: 10.1093/cei/uxaf024 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical and Experimental Immunology, online erschienen am 18.06.2025. Verfasst von Guanghua Zhu und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematopoietic Stem Cell Transplantation, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics…. Hauptthemen laut MEDLINE: CD18 Antigens, Hematopoietic Stem Cell Transplantation, Leukocyte-Adhesion Deficiency Syndrome, RNA Splicing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Beijing Municipal Health Commission.
Abstract (Originalsprache)
Leukocyte adhesion deficiency I (LAD-I) is an autosomal recessive immunodeficiency caused by mutations in the ITGB2 gene, characterized by recurrent severe infections, impaired pus formation, and delayed wound healing. In this study, we describe a late-onset presentation of LAD-I in a 22-year-old male who initially exhibited marked leukocytosis and neonatal omphalitis, followed by recurrent upper respiratory tract infections from 9 months of age. At age 13, the patient developed abdominal and left iliac fossa abscesses, which progressed to a vesicocutaneous fistula after a prolonged febrile episode. Extended catheterization and antibiotic treatment led to the formation of characteristic tin foil-like scarring. Recurrent purulent skin and soft tissue infections led to widespread scarring and pigmentary changes. Next-generation sequencing (NGS) identified a novel homozygous splice-site mutation in ITGB2 (NM_000211.5, c.1225-1G > A, IVS10-1G > A). In silico analysis predicted disruption of the acceptor site, while a minigene assay demonstrated two aberrant splicing events, namely a 12-bp deletion and complete skipping of exon 11 (188 bp). Flow cytometry analysis at age 13 showed CD18 expression reduced to less than 1% across granulocytes, monocytes, and lymphocytes, with concomitant decreases in β2-integrin α subunits (CD11a, CD11b, and CD11c). At 15 years of age, the patient underwent hematopoietic stem cell transplantation (HSCT) from a fully HLA-matched (10/10) heterozygous sister donor following a modified myeloablative conditioning regimen. Although initial chimerism fluctuated, full donor chimerism was ultimately achieved, restoring CD18 expression and normalizing ɑ-integrin levels. This study highlights the therapeutic efficacy of HSCT in correcting the molecular defects associated with LAD-I.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematopoietic Stem Cell Transplantation, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Chi…
- Deparment of Allergy, The First Hospital Affiliated to Tsinghua University, Beijing, China.
- Department of Pulmonology, Beijing Children's Hospital, Capital Medical University, National Clinical Research Center of Respiratory Diseases, National Center for Children's Health, Beijing, China.
- Diagnosis and Treatment Center of Gastroenterology and Hepatology, Inner Mongolia Xilinguo League Central Hospital, Xilinhot, China.
- Center of Clinical Laboratory, Inner Mongolia Xilinguo League Central Hospital , Xilinhot, China.
- Laboratory of Tumor Immunology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
ORCID-Profile: Jingang Gui, Wenjun Mou
Förderung
- Beijing Municipal Health Commission
Zitieren
APA
Zhu, G., Yue, H., He, J., Wang, C., Xu, C., Jia, C., Wang, X., Yan, Y., Wang, B., Zhang, H., Chen, X., Qiu, J., Gao, L., Zheng, J., Lv, G., Yang, J., Luo, Y., Qin, M., Gui, J., & Mou, W. (2025). An atypical adolescent case of leukocyte adhesion deficiency I caused by a novel ITGB2 splicing variant with successful immune reconstitution following hematopoietic stem cell transplantation. Clinical and Experimental Immunology, 219(1). https://doi.org/10.1093/cei/uxaf024
Vancouver
Zhu G, Yue H, He J, Wang C, Xu C, Jia C, et al. An atypical adolescent case of leukocyte adhesion deficiency I caused by a novel ITGB2 splicing variant with successful immune reconstitution following hematopoietic stem cell transplantation. Clinical and Experimental Immunology. 2025;219(1). doi:10.1093/cei/uxaf024
BibTeX
@article{Zhu2025,
author = {Zhu, Guanghua and Yue, Honghong and He, Jianxin and Wang, Caisheng and Xu, Chen and Jia, Chenguang and Wang, Xiaolin and Yan, Yan and Wang, Bin and Zhang, Hui and Chen, Xi and Qiu, Jianping and Gao, Liwei and Zheng, Jie and Lv, Ge and Yang, Jun and Luo, Yanhui and Qin, Maoquan and Gui, Jingang and Mou, Wenjun},
title = {An atypical adolescent case of leukocyte adhesion deficiency I caused by a novel ITGB2 splicing variant with successful immune reconstitution following hematopoietic stem cell transplantation},
journal = {Clinical and Experimental Immunology},
year = {2025},
volume = {219},
number = {1},
doi = {10.1093/cei/uxaf024}
}
EUVIMED